芋螺毒素MrIA的串联表达、纯化及生物活性鉴定

doi:10.13523/j.cb.20160512

PDF(768 KB)

中国生物工程杂志 ›› 2016, Vol. 36 ›› Issue (5) : 81-88. DOI: 10.13523/j.cb.20160512

研究报告

芋螺毒素MrIA的串联表达、纯化及生物活性鉴定

朱晓鹏^1,2,3, 张亚宁¹, 于津鹏¹, 李晓丹¹, 罗素兰^1,2, 长孙东亭^1,2

作者信息 +

Tandem Expression, Purification and Bioactivity Characterization of Conotoxin MrIA

ZHU Xiao-peng^1,2,3, ZHANG Ya-ning¹, YU Jin-peng¹, LI Xiao-dan¹, LUO Su-lan^1,2, ZHANGSUN Dong-ting^1,2

Author information +

文章历史 +

摘要

芋螺毒素(Conotoxins,CTxs)是一类特异作用于离子通道和膜受体的小分子多肽,是研究受体结构和功能及其相关疾病的重要工具。MrIA是进入临床研究可用于镇痛治疗的一种T超家族的芋螺毒素。传统获取芋螺毒素是通过化学合成的方法,成本高、产量低。实验利用串联表达技术,构建原核表达载体,在大肠杆菌(Escherichia coli,E. coli)中成功表达了芋螺毒素MrIA(recombinant MrIA,rMrIA)。通过溴化氰切割和纯化,最终1L菌液可获得纯度高达95%的rMrIA 30mg。小鼠热板实验表明,rMrIA具有较好的镇痛活性。这为大量获得MrIA以及其他芋螺毒素小肽的表达提供了方法。

Abstract

CTxs are small peptides which specific target variety of voltage-gated ion channels and membrane receptor. Conotoxins are important tools for the study of receptors structure and function and their related diseases. MrIA is a T-superfamily conotoxin which was entering clinical research for analgesia. The traditional methods to acquire conotoxin are chemical synthesis, while these methods are cost-consuming but low yields. Tandem repeats of mria gene fragment were constructed and ligated with prokaryotic expression vector. The rMrIA was expressed successfully in E.coli. 95% purity rMrIA were obtained by CNBr cleavage and purification, 30mg rMrIA could be obtained from 1L media eventually. Mice hot plate test showed that rMrIA had good analgesic activity. An effective method to obtain large quantities of MrIA and a model for other small conotoxins expression were provided.

导出引用

朱晓鹏, 张亚宁, 于津鹏, 李晓丹, 罗素兰, 长孙东亭. 芋螺毒素MrIA的串联表达、纯化及生物活性鉴定[J]. 中国生物工程杂志, 2016, 36(5): 81-88 https://doi.org/10.13523/j.cb.20160512

ZHU Xiao-peng, ZHANG Ya-ning, YU Jin-peng, LI Xiao-dan, LUO Su-lan, ZHANGSUN Dong-ting. Tandem Expression, Purification and Bioactivity Characterization of Conotoxin MrIA[J]. China Biotechnology, 2016, 36(5): 81-88 https://doi.org/10.13523/j.cb.20160512

中图分类号： Q78

参考文献

[1] Norton R S, Olivera B M. Conotoxins down under. Toxicon,2006,48(7):780-798.
[2] Olivera B M. Conus peptides:biodiversity-based discovery and exogenomics. J Biol Chem,2006,281(42):31173-31177.
[3] Olivera B M. E.E.Just Lecture,1996.Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology. Mol Biol Cell,1997,8(11):2101-2109.
[4] Davis J, Jones A, Lewis R J. Remarkable inter-and intra-species complexity of conotoxins revealed by LC/MS. Peptides,2009,30(7):1222-1227.
[5] Olivera B M, Rivier J, Clark C, et al.Diversity of Conus neuropeptides. Science,1990,249(4966):257-263.
[6] Robinson S D, Norton R S. Conotoxin gene superfamilies. Mar Drugs,2014,12(12):6058-6101.
[7] McIntosh J M, Corpuz G O, Layer R T, et al. Isolation and characterization of a novel conus peptide with apparent antinociceptive activity. J Biol Chem,2000,275(42):32391-32397.
[8] Balaji R A, Ohtake A, Sato K,et al. lambda-conotoxins, a new family of conotoxins with unique disulfide pattern and protein folding. Isolation and characterization from the venom of Conus marmoreus. J Biol Chem,2000,275(50):39516-39522.
[9] Goddard A W, Ball S G, Martinez J, et al. Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety,2010,27(4):339-350.
[10] Nielsen C K, Lewis R J, Alewood D, et al. Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain,2005,118(1-2):112-124.
[11] Lewis R J, Dutertre S, Vetter I, et al. Conus venom peptide pharmacology. Pharmacol Rev,2012,64(2):259-298.
[12] Casarrubea M, Sorbera F, Santangelo A, et al. The effects of diazepam on the behavioral structure of the rat's response to pain in the hot-plate test: anxiolysis vs. pain modulation. Neuropharmacology,2012,63(2):310-321.
[13] Lewis R J. Discovery and development of the χ-conopeptide class of analgesic peptides. Toxicon,2012,59(4):524-528.
[14] Brust A, Palant E, Croker D E, et al. chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. J Med Chem,2009,52(22):6991-7002.
[15] Kumar G S, Ramasamy P, Sikdar S K, et al. Overexpression, purification, and pharmacological activity of a biosynthetically derived conopeptide. Biochem Biophys Res Commun,2005,335(3):965-972.
[16] Bruce C, Fitches E C, Chougule N, et al. Recombinant conotoxin, TxVIA, produced in yeast has insecticidal activity. Toxicon,2011,58(1):93-100.
[17] Hruby V J. Designing peptide receptor agonists and antagonists. Nat Rev Drug Discov,2002,1(11):847-858.
[18] Sharpe I A, Palant E, Schroeder C I,et al. Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na⁺ dependence, and structure-activity relationship. J Biol Chem,2003,278(41):40317-40323.
[19] Kuliopulos A, Walsh C T. Production, purification, and cleavage of tandem repeats of recombinant peptides. J Am Chem Soc,1994,116(11):4599-4607.
[20] Hwang P M, Pan J S, Sykes B D.Targeted expression, purification, and cleavage of fusion proteins from inclusion bodies in Escherichia coli. FEBS Lett,2014,588(2):247-252.